41 results
Thumbnail

D1.44 - A Difficult to Treat Chronic Urticaria With Psychological Stress, High Anti-Thyroglobulin and De-labeling Hypersensitivity Reaction to Cetirizine

Thumbnail

D1.45 - Omalizumab Reduces Anaphylactic Reactions and Facilitates Food Introduction in Food-Allergic Children with Severe Asthma: A Case Report

Thumbnail

D1.48 - Challenging decisions: Feasibility and safety of multiple low-risk drug challenges in a single clinic visit during peri-operative anaphylaxis investigation

Thumbnail

D1.49 - Crossed-reactivity among Proton Pump Inhibitors in Immediate Severe Hipersensitivity Reactions

Thumbnail

D1.50 - Coconut Oil Anaphylaxis after Mucous Exposure, in a Patient with Primary Coconut Allergy

Thumbnail

D1.53 - Anaphylaxis to Beta-Lactams: The Importance of the Oral Challenge Test in Diagnosis

Thumbnail

D1.54 - Nut Allergy in the Spotlight: The Crucial Role of Oral Provocation Tests

Thumbnail

D1.55 - Assembling the Idiopathic Anaphylaxis Puzzle: Where was the secret key for Idiopathic anaphylaxis’s box?

Thumbnail

D1.46 - Allergic Reaction to Quadrivalent Meningococcal Conjugate Vaccine (MCV4): Case Report and Diagnostic Approach

Thumbnail

D1.309 - Association of Antenatal Corticosteroids with Risk of Autoimmune Diseases in Children: a Nationwide Cohort Study

Thumbnail

D1.308 - Case report: challenges in a long-term prophylaxis in hereditary angioedema (HAE)

Thumbnail

D1.310 - Phenotypes of patients with Hereditary Angioedema (HAE): a case series

Thumbnail

D1.311 - Treatment Dilemmas in CARMIL2 Deficiency

Thumbnail

D1.312 - Acquired C1-inhibitor deficiency angioedema treated with lanadelumab: a case series

Thumbnail

D1.313 - Inborn Error of Immunity Associated Inflammatory Bowel Disease at a Tertiary Care Center

Thumbnail

D1.315 - Classifying the unclassifiable: diagnosis, characterization, and management of adults with unclassified primary antibody deficiency (unPAD)

Thumbnail

D1.316 - Lessons Learned from the Diagnosis and Management of a female pediatric patient with NCF2 Mutations and Chronic Granulomatous Disease

Thumbnail

D1.317 - A Retrospective Analysis of Dengue-Associated Hemophagocytic Lymphohistiocytosis in a Dengue-Endemic Country

Thumbnail

D1.318 - Extending Lanadelumab Dosing Intervals to Every 4 Weeks With Sustained Effectiveness for Hereditary Angioedema Attack Prevention: An Analysis From the Final ENABLE Study Data

Thumbnail

D1.319 - The Silent Threat of Hereditary Angioedema in Children: Single Center Experience